UPDATE: JPMorgan Downgrades Diebold (DBD) to Underweight

March 27, 2020 4:46 AM EDT
Get Alerts DBD Hot Sheet
Price: $10.52 -1.77%

Rating Summary:
    6 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE
(Updated - March 27, 2020 4:53 AM EDT)

(updating comment)

JPMorgan analyst Paul Coster downgraded Diebold (NYSE: DBD) from Neutral to Underweight with a price target of $6.00 (from $8.00).

The analyst comments "DBD is trading at ~5.7x our revised 2020E PF EBITDA forecast, which is a discount to the three-year average of ~6.3x. The discount is warranted given the lack of growth, modest margins expansion, elevated debt leverage, as the firm enters a likely recession caused by the
COVID-19 response. The Underweight Rating is not a call to short this stock, but we do expect DBD to underperform the mean of our coverage in the next 6-12 months."

For an analyst ratings summary and ratings history on Diebold click here. For more ratings news on Diebold click here.

Shares of Diebold closed at $4.46 yesterday.


You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Downgrades, Hot Comments, Hot Downgrades

Related Entities

JPMorgan